Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

6.05
+0.13502.28%
Volume:349.31K
Turnover:2.10M
Market Cap:309.95M
PE:-1.78
High:6.08
Open:5.86
Low:5.80
Close:5.91
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:0.34
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.91
PE(LYR):6.50

Loading ...

Emergent BioSolutions Inc Expected to Post Earnings of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

GlobeNewswire
·
Jul 23

Wix and Elavon Launch Unified Commerce Solutions to Help Small Businesses Start, Grow and Scale

GlobeNewswire
·
Jul 07

Emergent Biosolutions SVP Paul Anthony Williams Sells 3,000 Shares for $25,200

Reuters
·
Jul 03

Emergent BioSolutions Secures New ACAM2000 Biodefense Contract

TIPRANKS
·
Jun 29

Emergent Gets $52.7 Million Contract Modification From US Government

MT Newswires Live
·
Jun 29

Emergent BioSolutions awarded $52.7M contract modification

TIPRANKS
·
Jun 29

Emergent Biosolutions Secures Contract Modification Valued at Approximately $52.7 Million for Acam2000® (smallpox and Mpox (vaccinia) Vaccine, Live) from the U.S. Government

THOMSON REUTERS
·
Jun 29

Emergent Biosolutions - Contract Modification Under Existing 10-year Contract with Aspr

THOMSON REUTERS
·
Jun 29

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

GlobeNewswire
·
Jun 04

Emergent BioSolutions awarded $64.5M HHS contract modification

TIPRANKS
·
May 29

BRIEF-Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy

Reuters
·
May 29

Emergent BioSolutions wins USD 64.5 million HHS contract modification for botulism antitoxin BAT

Reuters
·
May 29

Emergent BioSolutions Receives $64.5 Million Contract Modification for Bat® [Botulism Antitoxin Heptavalent (a, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy

THOMSON REUTERS
·
May 29

Emergent BioSolutions to present at Jefferies Global Healthcare Conference

Reuters
·
May 20

Saudi regulator SFDA approves Emergent ACAM2000 vaccine for smallpox, mpox prevention

Reuters
·
May 18

Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for Acam2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]

THOMSON REUTERS
·
May 18

Press Release: Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

TIPRANKS
·
May 02